Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
., Founding Director at the Wyss Institute for Biologically Inspired Engineering at Harvard University seeks outstanding postdoctoral applicants with expertise in lung biology, cancer biology, and/or
-
Post-Doctoral position in cancer immunotherapy, Institut Pasteur, Paris, FranceMobilizing helper CD4+ T cellsfor the activation of anti-tumor immunity in lung cancer. Team: Dendritic cells and adaptive
-
MEDICAL ONCOLOGIST - LUNG CANCER Requisition # 75922 Position Basics Type of Position OTHER Advertising Ends on: Extended Until Position is Filled Advertising Started on: Wednesday, June 24th, 2026
-
Apply to the position on the Scientific Affairs team at the International Association for the Study of Lung Cancer (IASLC). We are looking for a mission-oriented Scientific Program Manager with
-
EXPOGEN-AI project within the Digital Genomics Group, Cancer Genomics Program at CNIO. This is a unique opportunity to investigate how environmental exposures shape the genomic architecture of lung
-
We are seeking a motivated and collaborative individual to join our team as a Translational Research Programme Manager, working across the Lung (0.6 FTE) and Melanoma (0.4 FTE) research teams. This
-
Albert Einstein College of Medicine (Bronx, NY) | Bronx, New York | United States | about 2 months ago
cancer biology intersecting with one or more of the following areas: immunology, stem cell biology, aging, liver biology, or lung biology. Demonstrate solid expertise in cell biology and in vivo models
-
-ray imaging Translating new x-ray imaging techniques from the synchrotron to the laboratory Transforming breast cancer imaging with x-ray phase contrast Webpage: https
-
significant experience in clinical and translational oncology, with particular reference to lung cancer, immuno-oncology, predictive biomarkers, management of immune-related toxicities, and real-world
-
related to staff position within a Research Infrastructure? No Offer Description Lung cancer and mesothelioma remain among the deadliest cancers worldwide, highlighting the need for more effective and